Here are seven such studies that Becker’s has covered since March 15:
1. Death risk higher even for COVID-19 survivors with mild cases, study finds
COVID-19 survivors who were not hospitalized still had a higher risk of death and required more healthcare services within six months than people without the virus.
2. 68% of patients with mild case of COVID-19 get new diagnosis within 6 months, CDC finds
Two-thirds of nonhospitalized COVID-19 patients had at least one outpatient visit that resulted in a new diagnosis within six months of contracting the virus.
3. 33% of COVID-19 survivors later diagnosed with psychiatric issues, study finds
Among 236,379 people with a confirmed COVID-19 infection, nearly 34 percent were diagnosed with a neurological or psychological condition within six months.
4. What CDC researchers learned from studying 1,700 cases of MIS-C
Ninety percent of children with multisystem inflammatory syndrome in children — a rare condition possibly linked to COVID-19 — developed health issues involving at least four organs, and 31 percent had cardiac dysfunction.
5. Nearly 30% of hospitalized COVID-19 patients in UK readmitted, study finds
Nearly one-third of hospitalized COVID-19 patients in the U.K. were readmitted within 140 days, and they experienced multiorgan dysfunction at higher rates than those without COVID-19.
6. 52% of COVID-19 survivors report signs of depression
Of 3,904 who reported a prior COVID-19 infection in a research survey, 52.4 percent met the criteria for symptoms of major depressive disorder.
7. Not all COVID ‘long-haulers’ are adults
Early research shows cases of “long COVID” are rare among children, but are increasing as they return to in-person learning, sports and other activities. In February, Britain’s Office for National Statistics released figures that showed about 13 percent of children under 11 who contract COVID-19 still had at least one symptom after five weeks.
More articles on patient safety and outcomes:
Delay surgery for COVID-19 patients, study findings suggest
Why hospitals quietly ended convalescent plasma treatments
AHA urges CMS to reinstate survey pause if COVID-19 cases surge
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
